|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| A61P 3/00 | |||
| A61P 21/00 |
| (11) | Patento numeris | 1554312 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03758426.5 |
| Europos patento paraiškos padavimo data | 2003-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2003/004748 |
| Data | 2003-10-22 |
| (87) | Numeris | WO 2004/037861 |
| Data | 2004-05-06 |
| (30) | Numeris | Data | Šalis |
| 419964 P | 2002-10-22 | US |
| (72) |
VELDMAN, Geertruida, M., US
DAVIES, Monique, V., US
SONG, Kening, US
WOLFMAN, Neil, M., US
GROVE-BRIDGES, Kristie, US
FIELD, Anne, GB
RUSSELL, Caroline, GB
VALGE-ARCHER, Viia, GB
|
| (73) |
MEDIMMUNE LIMITED,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
Wyeth LLC, 235 East 42nd Street, New York, NY 10017, US |
| (54) | NEUTRALIZING ANTIBODIES AGAINST GDF-8 AND USES THEREFOR |
| NEUTRALIZING ANTIBODIES AGAINST GDF-8 AND USES THEREFOR |